Sol-Gel Technologies Ltd. NCM · SLGL
Price alert —
Sign in to get a one-time email the moment SLGL crosses your price. Free accounts included.
Sign in / create a free accountSol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustula…